Abundance of two human preadipocyte subtypes with distinct capacities for replication, adipogenesis, and apoptosis varies among fat depots

American Journal of Physiology - Endocrinology and Metabolism

Volumn 288, Issue 1 51-1, 2005, Pages

  Tchkonia, Tamara ^a   Tchoukalova, Yourka D ^d   Giorgadze, Nino ^a   Pirtskhalava, Tamar ^a   Karagiannides, Iordanes ^a   Forse, R Armour ^b   Koo, Ada ^c   Stevenson, Michael ^c   Chinnappan, Dharmaraj ^a   Cartwright, Andrew ^a   Jensen, Michael D ^d   Kirkland, James L ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^c AdipoGenix   (United States)

^d MAYO CLINIC   (United States)

Author keywords

CCAAT enhancer binding protein

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ABDOMEN; ADULT; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DIVISION; CELL FUNCTION; CELL MATURATION; CELL POPULATION; CELL SIZE; CELL SUBPOPULATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LIPID STORAGE; MALE; MESENTERY; OMENTUM; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION; SUBCUTANEOUS FAT;

ADIPOCYTES; ADIPOSE TISSUE; ADULT; APOPTOSIS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL COMMUNICATION; CELL DIVISION; CELLS, CULTURED; FEMALE; HUMANS; MALE; MIDDLE AGED; STEM CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 19944402860     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00265.2004     Document Type: Article

References (90)

1. Adams M, Montague CT, Prins JB, Holder JC, Smith SA, Sanders L, Digby JE, Sewter CP, Lazar MA, Chatterjee VK, and O'Rahilly S. Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. J Clin Invest 100: 3149-3153, 1997.
2. Adams M, Reginato MJ, Shao D, Lazar MA, and Chatterjee VK. Transcriptional activation by peroxisome proliferator-activated receptor γ is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J Biol Chem 272: 5128-5132, 1997.
3. Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, and Juhan-Vague I. Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 46: 860-867, 1997.
4. Arner P. Regional adiposity in man. J Endocrinol 155: 191-192, 1997.
5. Arner P, Hellstrom L, Wahrenberg H, and Bronnegard M. Beta-adrenoceptor expression in human fat cells from different regions. J Clin Invest 86: 1595-1600, 1990.
6. Bastelica D, Morange P, Berthet B, Borghi H, Lacroix O, Grino M, Juhan-Vague I, and Alessi MC. Stromal cells are the main plasminogen activator-1-producing cells in human fat: evidence of differences between visceral and subcutaneous deposits. Arterioscler Thromb Vasc Biol 22: 173-178, 2002.
7. Berman DM, Nicklas BJ, Rogus EM, Dennis KE, and Goldberg AP. Regional differences in adrenoreceptor binding and fat cell lipolysis in obese, postmenopausal women. Metabolism 47: 467-473, 1998.
8. Björntorp P. The regulation of adipose tissue distribution in humans. Int J Obes 20: 291-302, 1996.
9. Bluher M, Michael MD, Peroni OD, Ueki K, Carter N, Kahn BB, and Kahn CR. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev Cell 3: 25-38, 2002.
10. Bluher M, Patti ME, Gesta S, Kahn BB, and Kahn CR. Intrinsic heterogeneity in adipose tissue of fat-specific insulin receptor knockout mice is associated with differences in patterns of gene expression. [Online] J Biol Chem http://www.jbc.org/cgi/reprint/M404570200vl [May, 2004].
11. Bolinder J, Kager L, Ostman J, and Arner P. Differences at the receptor and postreceptor levels between human omental and subcutaneous adipose tissue in the action of insulin on lipolysis. Diabetes 32: 117-123, 1983.
12. Caserta F, Tchkonia T, Civelek V, Prentki M, Brown NF, McGarry JD, Forse RA, Corkey BE, Hamilton JA, and Kirkland JL. Fat depot origin affects fatty acid handling in cultured rat and human preadipocytes. Am J Physiol Endocrinol Metab 280: E238-E247, 2001.
13. Counter CM, Meyerson M, Eaton EN, Ellisen LW, Caddie SD, Haber DA, and Weinberg RA. Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase. Oncogene 16: 1217-1222, 1998.
14. Darlington GJ, Ross SE, and MacDougald OA. The role of C/EBP genes in adipocyte differentiation. J Biol Chem 273: 30057-30060, 1998.
15. Deckwerth TL and Johnson EM. Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor, J Cell Biol 123: 1207-1222, 1993.
16. DeMartinis FD. Very small fat cell populations determined by a modified osmium tetroxide-urea method. Am J Physiol Cell Physiol 249: C89-C96, 1985.
17. DeMartinis FD and Francendese A. Very small fat cell populations: mammalian occurrence and effect of age. J Lipid Res 23: 1107-1120, 1982.
18. Despres JP and Angel A. Scanning electron microscopy of very small fat cells and mature fat cells in human obesity. J Lipid Res 30: 293-299, 1989.
19. Digby J, Crowley V, Sewter C, Whitehead J, Prins J, and O'Rahilly S. Depot-related and thiazolidinedione-responsive expression of uncoupling protein 2 (UCP2) in human adipocytes. Int J Obes Relat Metab Disord 24: 585-592, 2000.
20. Djian P, Roncari DAK, and Hollenberg CH. Adipocyte precursor clones vary in capacity for differentiation. Metabolism 34: 880-883, 1985.
21. Djian P, Roncari DAK, and Hollenberg CH. Influence of anatomic site and age on the replication and differentiation of rat adipocyte precursors in culture. J Clin Invest 72: 1200-1208, 1983.
22. Dusserre E, Moulin P, and Vidal H. Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues. Biochim Biophys Acta 1500: 88-96, 2000.
23. Edens NK, Fried SK, Kral JG, Hirsch J, and Leibel RL. In vitro lipid synthesis in human adipose tissue from three abdominal sites. Am J Physiol Endocrinol Metab 265: E374-E379, 1993.
24. Entenmann G and Hauner H. Relationship between replication and differentiation in cultured human adipocyte precursor cells. Am J Physiol Cell Physiol 270: C1011-C1016, 1996.
25. Farmer SR. The forkhead transcription factor Foxol: a possible link between obesity and insulin resistance. Mol Cell 11: 1-2, 2003.
26. Fong R and Kissmeyer-Nielsen F. A combined dye-exclusion (trypan blue) and fluorochromatic technique for the microdroplet lymphocytotoxicity test. Tissue Antigens 2: 57-63, 1972.
27. Fried SK, Bunkin DA, and Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 83: 847-850, 1998.
28. Fried SK, Russell CD, Grauso NL, and Brolin RE. Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men. J Clin Invest 92: 2191-2198, 1993.
29. Green H and Kehinde O. Spontaneous heritable changes leading to increased adipose conversion in 3T3 cells. Cell 7: 105-113, 1976.
30. Gregoire FM, Smas CM, and Sul HS. Understanding adipocyte differentiation. Physiol Rev 78: 783-809, 1998.
31. Halleux CM, Declerck PJ, Tran SL, Detry R, and Brichard SM. Hormonal control of plasminogen activator inhibitor-1 gene expression and production by human adipose tissue: stimulation by glucocorticoids and inhibition by catecholamines. J Clin Endocrinol Metab 84: 4097-4105, 1999.
32. Harmelen V, Reynisdottir S, Eriksson P, Thorne A, Hoffstedt J, Lonnqvist F, and Arner P. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 47: 913-917, 1998.
33. Hartigan JA and Hartigan PM. The dip test of unimodality. Ann Stat 13: 70-84, 1985.
34. Hartigan PM. Computation of the dip statistic to test unimodality. Appl Statist 34: 320-325, 1985.
35. Hartman AD. Adipocyte fatty acid mobilization in vivo: effects of age and anatomical location. Lipids 20: 255-261, 1985.
36. Hauner H and Entenmann G. Regional variation of adipose differentiation in cultured stromal-vascular cells from the abdominal and femoral adipose tissue of obese women. Int J Obes 15: 121-126, 1991.
37. Hauner H, Entenmann G, Wabitsch M, Gaillard D, Ailhaud G, Negrel R, and Pfeiffer EF. Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. J Clin Invest 84: 1663-1670, 1989.
38. Hauner H, Petruschke T, Russ M, Rohrig K, and Eckel J. Effects of tumor necrosis factor alpha (TNFα) on glucose transport and lipid metabolism of newly-differentiated human fat cells in cell culture. Diabetologia 38: 764-771, 1995.
39. Hauner H, Wabitsch M, and Pfeiffer EF. Differentiation of adipocyte precursor cells from obese and nonobese adult women from different adipose tissue sites. Horm Metab Res 19, Suppl: 35-39, 1988.
40. Hellmér J, Marcus C, Sonnenfeld T, and Arner P. Mechanisms for differences in lipolysis between human subcutaneous and omental fat cells. J Clin Endocrinol Metab 75: 15-20, 1992.
41. Hube F, Lietz U, Igel M, Jensen PB, Tornqvist H, Joost HG, and Hauner H. Difference in leptin mRNA levels between omental and subcutaneous abdominal adipose tissue from obese humans. Horm Metab Res 28: 690-693, 1996.
42. Hutley LJ, Newell FM, Joyner JM, Suchting SJ, Herington AC, Cameron DP, and Prins JB. Effects of rosiglitazone and linoleic acid on human preadipocyte differentiation. Eur J Clin Invest 33: 574-581, 2003.
43. Kachigan SK. Statistical Analysis. New York: Radius, 1986.
44. Kelly I, Han T, Walsh K, and Lean M. Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes. Diabetes Care 22: 288-293, 1999.
45. Keppel G. Design and Analysis: A Researcher's Handbook. Englewood Cliffs, NJ: Prentice-Hall, 1973.
46. Kim N, Piatyszek M, Prowse K, Harley C, West M, Ho P, Coviello G, Wright W, Weinrich S, and Shay J. Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994.
47. Kirkland JL, Hollenberg CH, Gillon W, and Kindler S. Effect of hypophysectomy on rat preadipocyte replication and differentiation. Endocrinology 131: 2769-2773, 1992.
48. Kirkland JL, Hollenberg CH, and Gillon WS. Age, anatomic site, and the replication and differentiation of adipocyte precursors. Am J Physiol Cell Physiol 258: C206-C210, 1990.
49. Kirkland JL, Hollenberg CH, and Gillon WS. Effects of fat depot site on differentiation-dependent gene expression in rat preadipocytes. Int J Obes 20: S102-S107, 1996.
50. Kirkland JL, Hollenberg CH, and Gillon WS. Two preadipocyte subtypes cloned from human omental fat. Obesity Res 1: 87-91, 1993.
51. Kirkland JL, Hollenberg CH, Kindler S, and Gillon WS. Effects of age and anatomic site on preadipocyte number in rat fat depots. J Gerontol 49: B31-B35, 1994.
52. Kirkland JL, Tchkonia T, Giogadze N, and Pirtskhalava T. Adipose tissue as an endocrine organ: Regional differences in adipocyte endocrine function. Prog Obesity Res 9: 87-95, 2003.
53. Kirkland JL, Tchkonia T, Pirtskhalava T, Han J, and Karagiannides I. Adipogenesis and aging: Does aging make fat go MAD? Exp Gerontol 37: 757-767, 2002.
54. Kissebah AH and Hennes MMI. Central obesity and free fatty acid metabolism. Prostaglandins Leukot Essent Fatty Adds 52: 209-211, 1995.
55. Kissebah AH and Krakower GR. Regional adiposity and morbidity. Physiol Rev 74: 761-811, 1994.
56. Kleinbaum D, Kupper L, and Muller K. Applied Regression Analysis and Other Multivariate Methods. Belmont, CA: Duxbury, 1998.
57. Lacasa D, Garcia E, Agli B, and Giudicelli Y. Control of rat preadipocyte adipose conversion by ovarian status: regional specificity and possible involvement of the mitogen-activated protein kinase-dependent and c-fos signaling pathways. Endocrinology 138: 2729-2734, 1997.
58. Large V and Arner P. Regulation of lipolysis in humans. Pathophysiological modulation in obesity, diabetes, and hyperlipidaemia. Diabetes Metab 24: 409-418, 1998.
59. Lefebvre AM, Laville M, Vega N, Riou JP, van Gaal L, Auwerx J, and Vidal H. Depot-specific differences in adipose tissue gene expression in lean and obese subjects. Diabetes 47: 98-103, 1998.
60. Lin FT and Lane MD. CCAAT/enhancer binding protein α is sufficient to initiate the 3T3-L1 adipocyte differentiation program. Proc Natl Acad Sci USA 91: 8757-8761, 1994.
61. Lowell BB. PPARγ: An essential regulator of adipogenesis and modulator of fat cell function. Cell 99: 239-242, 1999.
62. MacDougald OA and Lane MD. Transcriptional regulation of gene expression during adipocyte differentiation. Anna Rev Biochem 64: 345-373, 1995.
63. Miller WH, Faust IM, and Hirsch J. Demonstration of de novo production of adipocytes in adult rats by biochemical and radioautographic techniques. J Lipid Res 25: 336-347, 1984.
64. Montague CT, Prins JB, Sanders L, Digby JE, and O'Rahilly S. Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. Diabetes 46: 342-347, 1997.
65. Montague CT, Prins JB, Sanders L, Zhang J, Sewter CP, Digby J, Byrne CD, and O'Rahilly S. Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes 47: 1384-1391, 1998.
66. Moorhead PS, Nowell PC, Mellman WJ, Battips D, and Hungerford D. Chromosome preparations from leukocytes cultured from human peripheral blood. Exp. Cell Res 20: 613-615, 1960.
67. Mori Y, Murakawa Y, Okada K, Horikoshi H, Yokoyama J, Tajima N, and Ikeda Y. Effect of troglitazone on body fat distribution in type 2 diabetic patients. Diabetes Care 22: 288-293, 1999.
68. Morrison RF and Farmer SM. Role of PPARγ in regulating a cascade expression of cyclin dependent kinase inhibitors, p18 (INK4c) and p21 (Waf1/Cip1), during adipogenesis. J Biol Chem 274: 17088-17097, 1999.
69. Niesler CU, Prins JB, O'Rahilly S, Siddle K, and Montague CT. Adipose depot-specific expression of cIAP2 in human preadipocytes and modulation of expression by serum factors and TNF alpha, Int J Obes Relat Metab Disord 25: 1027-1033, 2001.
70. Niesler CU, Siddle K, and Prins JB. Human preadipocytes display a depot-specific susceptibility to apoptosis. Diabetes 47: 1365-1368, 1998.
71. Östman J, Arner P, Engfeldt P, and Kager L. Regional differences in the control of lipolysis in human adipose tissue. Metabolism 28: 1198-1205, 1979.
72. Prins JB and O'Rahilly S. Regulation of adipose cell number in man. Clin Sci (Colch) 92: 3-11, 1997.
73. 2. Metabolism 40: 990-996, 1991.
74. Salter AM, Fong BS, Jimenez J, Rotstein L, and Angel A. Regional variation in high-density lipoprotein binding to human adipocyte plasma membranes of massively obese subjects. Eur J Clin Invest 17: 16-22, 1987.
75. Shahparaki A, Grunder L, and Sorisky A. Comparison of human abdominal subcutaneous versus omental preadipocyte differentiation in primary culture. Metabolism 51: 1211-1215, 2002.
76. Shimomura I, Funahashi T, Takahashi M, Maeda K, Kotani K, Nakamura T, Yamashita S, Miura M, Fukuda Y, Takemura K, Tokunaga K, and Matsuzawa Y. Enhanced expression of PAI-1 in visceral fat: Possible contributor to vascular disease in obesity. Nat Med 2: 800-803, 1996.
77. Smas CM and Sul HS. Control of adipocyte differentiation. Biochem J 309: 697-710, 1995.
78. Tchkonia T, DePonte M, Forse MA, Pirtskhalava T, and Kirkland JL. Telomerase expression enhances differentiation of passaged human preadipocytes. Obesity Res 9, Suppl 3: 145S, 2001.
79. Tchkonia T, Giorgadze N, Pirtskhalava T, Tchoukalova Y, Karagiannides I, Forse RA, DePonte M, Stevenson M, Guo W, Han J, Waloga G, Lash TL, Jensen MD, and Kirkland JL. Fat depot origin affects adipogenesis in primary cultured and cloned human preadipocytes. Am J Physiol Regul Integr Comp Physiol 282: R1286-R1296, 2002.
80. Tchkonia T, Karagiannides I, Forse RA, and Kirkland JL. Different fat depots are distinct mini-organs. Curr Opin Endocrinol Diabetes 8: 227-234, 2001.
81. Van de Ventner M, Litthauer D, and Oelofsen W. Catecholamine stimulated lipolysis in differentiated human preadipocytes in a serum-free, defined medium. J Cell Biochem 54: 1-10, 1994.
82. Van Harmelen V, Dicker A, Ryden M, Hauner H, Lonnqvist F, Naslund E, and Arner P. Increased lipolysis and decreased leptin production by human omental as compared with subcutaneous preadipocytes. Diabetes 51: 2029-2036, 2002.
83. Van Harmelen V, Rohrig K, and Hauner H. Comparison of proliferation and differentiation capacity of human adipocyte precursor cells from the omental and subcutaneous adipose tissue depot of obese subjects. Metabolism 53: 632-637, 2004.
84. Vikman HL, Kaartinen JM, Tuominen RK, and Ohisalo JJ. A possible role for protein kinase C in the regulatory differences between intra-abdominal and subcutaneous human adipose tissue. Clin Sci (Colch) 85: 265-268, 1993.
85. Vikman HL, Savola JM, Raasmaja A, and Ohisalo JJ. Alpha 2A-adrenergic regulation of cyclic AMP accumulation and lipolysis in human omental and subcutaneous adipocytes. Int J Obes 20: 185-189, 1996.
86. Wang H, Kirkland JL, and Hollenberg CH. Varying capacities for replication of rat adipocyte precursor clones and adipose tissue growth. J Clin Invest 83: 1741-1746, 1989.
87. Westergren-Thorsson G, Onnervik PO, Fransson LA, and Malmstrom A. Proliferation of cultured fibroblasts is inhibited by L-iduronate-containing glycosaminoglycans. J Cell Physiol 147: 523-530, 1991.
88. Yeh WC, Cao M, Classon M, and McKnight SL. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev 9: 168-181, 1995.
89. Zhou YT, Wang ZW, Higa M, Newgard CB, and Unger RH. Reversing adipocyte differentiation: implications for treatment of obesity. Proc Natl Acad Sci USA 96: 2391-2395, 1999.
90. Zierath JR, Livingston JN, Thorne A, Bounder J, Reynisdottir S, Lonnqvist F, and Arner P. Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: relation to insulin receptor phosphorylation and intracellular signaling through the insulin receptor substrate-1 pathway. Diabetologia 41: 1343-1354, 1998.